Article thumbnail

Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy.

By M. Pecherstorfer, Z. Herrmann, J.J. Body, C. Manegold, M. Degardin, M.R. Clemens, B. Thürlimann, M. Tubiana-Hulin, E.U. Steinhauer, M. van Eijkeren, H.J. Huss and D. Thiébaud
Topics: Adult; Aged; Aged, 80 and over; Bone Resorption; Calcium/blood; Diphosphonates/adverse effects; Diphosphonates/pharmacology; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fever/chemically induced; Humans; Hypercalcemia/blood; Hypercalcemia/drug therapy; Male; Middle Aged; Nausea/chemically induced; Neoplasms/complications; Recurrence; Regression Analysis; Thrombocytopenia/chemically induced; Treatment Outcome
Year: 1996
OAI identifier:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)

  • To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

    Suggested articles